Eirini Papapetrou, MD, PhD
@PapapetrouMDPhD
Professor @IcahnMountSinai & Director, Center for Advancement of Blood Cancer Therapies. Human iPSC models & CRISPR for blood cancers #IPSClove
🎉Excited to present our latest work out today @Nature 1.What gives a leukemia its phenotype – the oncogenic driver or the differentiation stage of the cell-of-origin? 2.Why do RAS mutations always happen late in AML? 3.Who will relapse after VEN? nature.com/articles/s4158…
In my reading list!
It finally here 🥳 brnw.ch/21wTSQI If you’re like us & your (professional) 🌍 revolves around myeloid neoplasms we hope you’ll enjoy reading this paper. So many colleagues & collaborators to 🙏🏻 for helping us get this to 🏁 … tweetorial & acknowledgements coming soon…
We are excited to announce that The Myeloid Workshop is back on under ASH this year and will be held on Friday, Dec 5, from 3-7PM. ...👇
@PapapetrouMDPhD/ Sturgeon/@Elvin_Wag /@FrancoIzzo85 /Noval labs summer party fun!
Welcoming @Doulatov_lab to the NYC blood community with @SKousteni!
Congratulations @sanamloghavi @PapaemmanuilLab @Elsa2Bernard and team! Looking forward to digging into this.
🚨 New paper! 🚨 brnw.ch/21wTSQI myeloid neoplasms w/ a data-driven twist! 📊 Our latest in @BCD_AACR addresses classification gaps in the 🌎 of myeloid neoplasms 🧵 led by @CLachowiez in collaboration w/@PapaemmanuilLab @Elsa2Bernard & a huge team of amazing friends…
Fantastic work, so many implications for human physiology and disease! Congrats @pvyas_oxford and team!
Detecting and quantifying clonal selection in somatic stem cells | Nature Genetics. So pleased to share this work. It is one of the most important pieces of work we have done. Huge thanks to all. More improvements on SCIFER to come! nature.com/articles/s4158…
Congratulations @LeonidasPlatan1
Receiving an honorary degree from the University of Athens. @LurieCancer @NUFeinbergMed
Thank you @KarsanAly for this insightful commentary on our paper in today’s issue of Blood @ASH_hematology ashpublications.org/blood/article/…
Looking forward to reading this!
Excited to share our latest study, led by @CLachowiez & @sanamloghavi on the relevance of data informed metrics in setting guidelines for disease classification in myeloid neoplasms.
Excited to share our latest study, led by @CLachowiez & @sanamloghavi on the relevance of data informed metrics in setting guidelines for disease classification in myeloid neoplasms.
Happy to share our newest work out today in BCD evaluating disease classification and prognosis in the “world of myeloid malignancies”! Wonderful collaboration with @sanamloghavi @PapaemmanuilLab @Elsa2Bernard and colleagues.
Thank you for having me! Always a distinct pleasure to interact with such a stellar and insightful group of colleagues @MDAndersonNews
Happening now at @MDAndersonNews Leukemia GR … excited to hear @PapapetrouMDPhD speak today
Completing the evaluation of @BSRC_Fleming with @LeonidasPlatan1 and @iannisaifantis1 in Vouliagmeni Athens.
Looking forward to a day of Greek science with @iannisaifantis1 @LeonidasPlatan1 and colleagues @BSRC_Fleming
At Alexander Fleming Research Center in Athens @BSRC_Fleming with @iannisaifantis1 and @PapapetrouMDPhD, as invited external reviewers.
Great lab! Cool science! Apply!👇
Be part of the Wagenblast Lab! We are hiring a Lab Manager for leukemia & blood stem cell research at @IcahnMountSinai in NYC, starting July 2025. See ad to apply!
I really enjoyed meeting new colleagues at the Cancer Center Amsterdam retreat, thank you @MariaThemeli1 for inviting me and for being such a great host!
A wonderful visit to Ghent University and beautiful and sunny Ghent with amazing host @PanosNtz. Thank you so much for a very memorable visit!
Congratulations to all highly deserving colleagues recognized by this year ‘s ASH honorific awards for their valuable contributions to hematology!
ASH is proud to recognize 11 hematologists whose groundbreaking research and leadership have transformed the understanding and care of blood disorders. Congratulations to all! 👏 🔗 ow.ly/EsgX50WbEwx #Hematology #ASHAwards
Really cool new paper out in @NatureGenet 👇
🚨🚨Paper out! 🚨🚨 Delighted to share our work, now published in @NatureGenet 🧬! shorturl.at/94s5S We identified a targetable, chromothripsis-associated genetic event in blast phase (BP) MPN, a particularly poor prognostic subtype of acute leukaemia. 1/n 🧵👇
Feeling like the worst “Rainy Day” has hit your hematology lab? ASH is deploying some significant umbrellas. More details soon! Watch #ASH
I discuss the urgent crisis from the loss of federal support of science in the US and recent clinical gene editing breakthroughs with @WalterIsaacson & @amanpour on @AmanpourCoPBS, airing on @PBS tonight at 11 pm ET, and on @cnni earlier today. Pls share! youtube.com/watch?v=8YhJM6…